Financials

News Discussions Technicals Forecast Seasonals

ALOPM fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. It has built a unique precision medicine platform dedicated to cancerous diseases and other diseases without therapeutic solution. Its innovative platform for the selection of new therapeutic targets has been developed on the basis of patient data and through a novel approach using Artificial Intelligence. The company was founded on December 15, 2020 and is headquartered in Dijon, France.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

ALOPM has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company